Cyclic On-off Switching of Pulmonary Blood Flow in Moderate to Severe ARDS

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-75
SponsorSoutheast University, China

About this trial

Although the theoretical model of "cyclic on-off switching of pulmonary blood flow" provides a crucial perspective for understanding VILI, its clinical validation and real-time intervention face significant obstacles. The fundamental reason lies in the lack of pulmonary microcirculation monitoring technology capable of bedside, non-invasive, continuous operation with sufficient spatiotemporal resolution. Nowadays, a novel 3D-EIT can perform real-time and non-invasive assessment of the distribution of pulmonary blood flow. However, if 3D-EIT can help to identify "cyclic on-off switching of pulmonary blood flow" is still unclear.

Eligibility criteria

Qualifiers

Adult patients with mechanical ventilation

diagnosis of moderate to severe ARDS no more than 72 hours

Disqualifiers

Chronic respiratory diseases that required long-term oxygen therapy, such as pulmonary fibrosis or chronical obstructive pulmonary disease

Contraindications to EIT (e.g., active implantable device, chest malformation, unstable spinal injuries or fractures, and open chest wounds)

Undrained pneumothorax or pneumomediastinum,

Hemodynamic instability

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

40 Participants
are grouped into 3 trial groups

Sponsors and collaborators